Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-3.63	19.18	19.90
Graham Fair Price	0.00	5.49	5.49
PEG	inf	0.00	0.03
Price/Book	-5.24	0.64	0.68
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-5.24	4.90	5.17
Price/Sales	-5.24	6.39	6.74
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.56	0.56
Operating Margin	0.00	0.39	0.39
ROA	0.00	0.01	0.01
ROE	0.03	0.03	0.00
ROIC	0.02	0.02	0.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.03	inf
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.17	0.00	inf
EPS QOQ	1.67	0.00	inf
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	0.16	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-53.07	-53.07	0.00
Days Sales Outstanding (DSO)	6.85	6.85	0.00
Inventory Turnover	-1.70	-1.70	0.00
Debt/Capitalization	0.36	0.36	0.00
Quick Ratio	0.69	0.69	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	6.39	6.39	0.00
Cash	1.99	1.99	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	0.64	0.64	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.77	0.77	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.13	6.13	0.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating